Agile Therapeutics(AGRX)

0.3200 -0.0500 -13.513514%

今开:0.333昨收:0.37
最高:0.405 最低:0.313
涨停价:0.0跌停价:0.0
总市值:948370.0

Agile Therapeutics的热门讨论

当期报告

Agile Therapeutics(AGRX)03-28 21:15

$Agile Therapeutics(AGRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-004174  Act: 34  Size: 503 KB 网页链接查看全文

当期报告

Agile Therapeutics(AGRX)03-26 04:35

$Agile Therapeutics(AGRX)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001558370-24-003854  Act: 34  Size: 207 KB 网页链接查看全文

当期报告

Agile Therapeutics(AGRX)03-15 04:55

$Agile Therapeutics(AGRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001558370-24-003246  Act: 34  Size: 192 KB 网页链接查看全文

当期报告

Agile Therapeutics(AGRX)02-24 05:45

$Agile Therapeutics(AGRX)$ 8-K Current report, items 1.01, 3.02, 3.03, 8.01, and 9.01 Accession Number: 0001558370-24-001624  Act: 34  Size: 803 KB 网页链接查看全文

招股说明书

Agile Therapeutics(AGRX)02-24 06:05

$Agile Therapeutics(AGRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-027083  Act: 33  Size: 22 KB 网页链接查看全文

招股说明书

Agile Therapeutics(AGRX)02-24 06:05

$Agile Therapeutics(AGRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-24-027084  Act: 33  Size: 21 KB 网页链接查看全文

当期报告

Agile Therapeutics(AGRX)02-16 05:55

$Agile Therapeutics(AGRX)$ 8-K Current report, items 1.01, 2.02, 8.01, and 9.01 Accession Number: 0001558370-24-001247  Act: 34  Size: 250 KB 网页链接查看全文

超过5%股东持股披露「修订」

Agile Therapeutics(AGRX)02-14 09:05

$Agile Therapeutics(AGRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000556  Act: 34  Size: 76 KB 网页链接查看全文

招股说明书「补充」

Agile Therapeutics(AGRX)02-05 22:25

$Agile Therapeutics(AGRX)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-24-010379  Act: 33  Size: 915 KB 网页链接查看全文

超过5%股东持股披露「修订」

Agile Therapeutics(AGRX)02-06 23:25

$Agile Therapeutics(AGRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-010313  Act: 34  Size: 56 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48

Agile Therapeutics的最新讨论

逍遥投资派2023-05-13 19:38

$Agile Therapeutics(AGRX)$ 2020年产生少量营收,2022年增长到1100万,营业利润和净利润继续大幅亏损,目前缺乏投资价值。查看全文

反贾骗联盟首席2022-07-11 14:34

$Agile Therapeutics(AGRX)$ $Evofem Biosciences(EVFM)$ 这两个标的一起来看,信息比较稀少,需要仔细看IR和SEC的内容,方向了解还比较少,是个新的有潜力的细分方向查看全文

David_51982021-02-10 02:16

$Agile Therapeutics(AGRX)$ 女性避孕贴,图形漂亮[笑]查看全文

涅槃重生之银河2019-11-15 22:50

$Agile Therapeutics(AGRX)$ 好惨,幸亏昨晚遵循赌股不过夜的原则2.45跑了[鼓鼓掌][鼓鼓掌][鼓鼓掌]查看全文

郁闷的鞋套-2019-11-15 12:04

$Agile Therapeutics(AGRX)$ FDA还能这么玩啊。。。。$阿玛琳(AMRN)$ 会不会有点瑟瑟发抖。。。查看全文

1 2 3 4 5 6 7 8 9

Agile Therapeutics的新闻

Agile Therapeutics盘前大涨35% 与VitaCare处方服务公司达成新协议

来源:格隆汇 格隆汇6月14日丨Agile Therapeutics(AGRX.US)盘前涨35.65%,报4.87美元。Agile Therapeutics宣布与VitaCare处方服务公司达成新协议,以扩大Twirla的使用范围,推动公司2023年实现净收入2500万至30... 网页链接

Agile Therapeutics的公告

持股变动声明

$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-126012  Size: 6 KB 网页链接

持股变动声明

$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-126014  Size: 7 KB 网页链接

招股说明书

$Agile Therapeutics(AGRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-21-124717  Act: 33  Size: 596 KB 网页链接

当期报告

$Agile Therapeutics(AGRX)$ 8-K Current report, items 5.02, 7.01, 8.01, and 9.01 Accession Number: 0001104659-21-124720  Act: 34  Size: 630 KB 网页链接

首次持股声明

$Agile Therapeutics(AGRX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-21-124697  Size: 9 KB 网页链接

持股变动声明

$Agile Therapeutics(AGRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-21-124699  Size: 7 KB 网页链接

招股说明书

$Agile Therapeutics(AGRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-21-124246  Act: 33  Size: 596 KB 网页链接

当期报告

$Agile Therapeutics(AGRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001558370-21-012978  Act: 34  Size: 229 KB 网页链接

当期报告

$Agile Therapeutics(AGRX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-21-012390  Act: 34  Size: 3 MB 网页链接

当期报告

$Agile Therapeutics(AGRX)$ 8-K Current report, items 1.01 and 2.03 Accession Number: 0001558370-21-010826  Act: 34  Size: 154 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46